Author: Atta-ur-Rahman

Frontiers in Clinical Drug Research; Anti-Infectives

Volume 4

eBook: US $39 Special Offer (PDF + Printed Copy): US $138
Printed Copy: US $119
Library License: US $156
ISSN: 2452-3208 (Print)
ISSN: 2352-3212 (Online)
ISBN: 978-1-68108-488-6 (Print)
ISBN: 978-1-68108-487-9 (Online)
Year of Publication: 2017
DOI: 10.2174/97816810848791170401

Introduction

Frontiers in Clinical Drug Research – Anti infectives is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of infectious diseases. The scope of the eBook series covers a range of topics including the chemistry, pharmacology, molecular biology and biochemistry of natural and synthetic drugs employed in the treatment of infectious diseases. Reviews in this series also include research on multi drug resistance and pre-clinical / clinical findings on novel antibiotics, vaccines, antifungal agents and antitubercular agents. Frontiers in Clinical Drug Research – Anti infectives is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in the field of anti infective drug discovery and epidemiology.

The fourth volume of this series features reviews that cover a variety of topics including:

  1. -Strategies to prolong antibiotic life
  2. -Catalytic antibodies for targeting rabies and influenza viruses
  3. -Antiviral therapies for arenaviruses
  4. -The role of steroids in viral infections
  5. -Monoclonal antibody manufacturing processes
  6. -Prevention and eradication of biofilms in medical devices

Preface

- Pp. i
Atta-ur- Rahman
Download Free

List of Contributors

- Pp. ii-iii (2)
Atta-ur- Rahman
Download Free

Strategies to Prolong the Useful Life of Existing Antibiotics and Help Overcoming the Antibiotic Resistance Crisis

- Pp. 1-27 (27)
Marcelo E. Tolmasky
View Abstract

Preparation and Perspectives of Catalytic Antibodies Possessing Characteristic Ability to Inhibit Infection Against Viruses such as Influenza and Rabies

- Pp. 28-57 (30)
Emi Hifumi, Mitsue Arakawa, Taizo Uda
View Abstract

Recent Advances in the Development of Antiviral Approaches against Hemorrhagic-Fever-Causing Arenaviruses

- Pp. 58-92 (35)
Viviana Castilla, Jesus E. Brunetti, Maria N. Armiento, Luis A. Scolaro
View Abstract

The New Role of Steroids in Viral Infections

- Pp. 93-141 (49)
Gabriel F. Gola, Andrea C. Bruttomesso, Andrea A. Barquero, Javier A. Ramirez
View Abstract

Monoclonal Antibodies – Addressing the Challenges on the Manufacturing Processing of an Advanced Class of Therapeutic Agents

- Pp. 142-203 (62)
Emanuel V. Capela, Maria Raquel Aires-Barros, Mara G. Freire, Ana M. Azevedo
View Abstract

Prevention and Eradication of Biofilm in Medical Indwelling Devices

- Pp. 204-248 (45)
Maria Manuel Azevedo, Luis Cobrado, Ana Silva-Dias, Cidalia Pina- Vaz, Acacio Goncalves Rodrigues
View Abstract

Subject Index

- Pp. 249-258 (10)
Atta-ur- Rahman
Download Free

RELATED BOOKS

.An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy.
.COVID-19: Effects in Comorbidities and Special Populations.
.Current Developments in the Detection and Control of Multi Drug Resistance.
.Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences.